Research paperA novel hemolytic complement-sufficient NSG mouse model supports studies of complement-mediated antitumor activity in vivo
Keywords: Immunotherapy; Complement-dependent cytotoxicity (CDC); Patient-derived xenograft (PDX); NSG mice; Monoclonal antibody (mAb);